ArticleBreast cancer research : BCR2020

A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using

Agnes Jager et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.